Skip to content

Clinical trials

Phase 3 Musculoskeletal Diseases trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Musculoskeletal Diseases Phase: Phase 3 Country / region: Germany Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20092
20122
20131
20141
20152
20163
20173
20181
20191
20221
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Active, not recruiting4
Terminated3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie6
BioMarin Pharmaceutical3
Amgen2
Catabasis Pharmaceuticals2
Genzyme, a Sanofi Company2
PTC Therapeutics2
Regeneron Pharmaceuticals2
Avidity Biosciences, Inc.1
Eli Lilly and Company1
Fulcrum Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Musculoskeletal Diseases22
Arthritis9
Joint Diseases9
Genetic Diseases, Inborn8
Muscular Dystrophies6
Neuromuscular Diseases6
Arthritis, Rheumatoid5
Bone Diseases5
Muscular Dystrophy, Duchenne5
Bone Diseases, Developmental3

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.